Sign up to save your podcasts
Or
Share AAV. Resources on cureSYNGAP1.org. Congrats to Ultragenyx & Novartis. Conf is in 5 days! #S10e190
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AAV. Resources on cureSYNGAP1.org. Congrats to Ultragenyx & Novartis. Conf is in 5 days! #S10e190
Happy Thanksgiving… Thursday, November 27, 2025. Week 48.
Continued from #S10e189…
And the AAV Paper (https://pubmed.ncbi.nlm.nih.gov/40988338/) from #S10e187… https://curesyngap1.org/podcasts/syngap10/clinical-research-ai-dx-nl47-survey-autism-press-6-days-to-register-for-syngap1conf-s10e187/
https://curesyngap1.org/blog/
Issac’s story, Transmitter reprint, Scramble 4 write up and JK on #Autism, #MustRead
https://curesyngap1.org/resources/webinars/ 119 - 112
Register for livestream of the conference, AAV from Allen Inst., dos en espanol, Missense, Unlock and Rare-X for ProMMiS.
https://curesyngap1.org/podcasts/syngap1-stories/
A gold mine have you listened to #38, the Virginie Pod, really must listen, she is our leader. https://www.linkedin.com/posts/graglia_syngap1stories-syngap1-syngap1storiesty-activity-7387203351907708928-liNL
CLINICAL TRIAL & GENETIC MEDICINE CORNER
Example of Ultragenyx FAST Angelman follow on trial to look at other ages and genotypes, key message, never give up. https://www.linkedin.com/posts/cureangelman_the-global-aurora-study-will-enroll-approximately-activity-7389647402690957312-Bihi
Congrats to Novartis on approval of the first Gene Therapy to Cure SMA!
https://www.linkedin.com/posts/graglia_sma-fdaapproval-rarediseaseinnovation-activity-7398939783005347840-Ocd_ Remember Spinraza was approved in December 2019.
TODOS
SOCIAL MATTERS
4,468 LinkedIn. https://www.linkedin.com/company/curesyngap1/
1,480 YouTube. https://www.youtube.com/@CureSYNGAP1
11.2k Twitter https://twitter.com/cureSYNGAP1
45k Insta https://www.instagram.com/curesyngap1/
$CAMP stock is at $3.62 on 26 Nov. ‘25 https://www.google.com/finance/beta/quote/CAMP:NASDAQ
Episode 190 of #Syngap10 #CureSYNGAP1
View all episodes
By Syngap Research Fund, 501(c)(3)
5
8585 ratings
Happy Thanksgiving… Thursday, November 27, 2025. Week 48.
Continued from #S10e189…
And the AAV Paper (https://pubmed.ncbi.nlm.nih.gov/40988338/) from #S10e187… https://curesyngap1.org/podcasts/syngap10/clinical-research-ai-dx-nl47-survey-autism-press-6-days-to-register-for-syngap1conf-s10e187/
https://curesyngap1.org/blog/
Issac’s story, Transmitter reprint, Scramble 4 write up and JK on #Autism, #MustRead
https://curesyngap1.org/resources/webinars/ 119 - 112
Register for livestream of the conference, AAV from Allen Inst., dos en espanol, Missense, Unlock and Rare-X for ProMMiS.
https://curesyngap1.org/podcasts/syngap1-stories/
A gold mine have you listened to #38, the Virginie Pod, really must listen, she is our leader. https://www.linkedin.com/posts/graglia_syngap1stories-syngap1-syngap1storiesty-activity-7387203351907708928-liNL
CLINICAL TRIAL & GENETIC MEDICINE CORNER
Example of Ultragenyx FAST Angelman follow on trial to look at other ages and genotypes, key message, never give up. https://www.linkedin.com/posts/cureangelman_the-global-aurora-study-will-enroll-approximately-activity-7389647402690957312-Bihi
Congrats to Novartis on approval of the first Gene Therapy to Cure SMA!
https://www.linkedin.com/posts/graglia_sma-fdaapproval-rarediseaseinnovation-activity-7398939783005347840-Ocd_ Remember Spinraza was approved in December 2019.
TODOS
SOCIAL MATTERS
4,468 LinkedIn. https://www.linkedin.com/company/curesyngap1/
1,480 YouTube. https://www.youtube.com/@CureSYNGAP1
11.2k Twitter https://twitter.com/cureSYNGAP1
45k Insta https://www.instagram.com/curesyngap1/
$CAMP stock is at $3.62 on 26 Nov. ‘25 https://www.google.com/finance/beta/quote/CAMP:NASDAQ
Episode 190 of #Syngap10 #CureSYNGAP1
More shows like CURE SYNGAP1 PODCAST aka SYNGAP10
View all
Fantasy Footballers - Fantasy Football Podcast
29,720 Listeners
The Daily
111,848 Listeners
SYNGAP1 Stories
29 Listeners
Café SYNGAP1
19 Listeners